000 | 01822 a2200541 4500 | ||
---|---|---|---|
005 | 20250513220242.0 | ||
264 | 0 | _c20001002 | |
008 | 200010s 0 0 eng d | ||
022 | _a0143-3334 | ||
024 | 7 |
_a10.1093/carcin/21.9.1661 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWalker, V E | |
245 | 0 | 0 |
_aBiomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide. _h[electronic resource] |
260 |
_bCarcinogenesis _cSep 2000 |
||
300 |
_a1661-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers _xanalysis |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aCarcinogens _xpharmacokinetics |
650 | 0 | 4 |
_aDNA _xdrug effects |
650 | 0 | 4 | _aDNA Damage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEthylene Oxide _xmetabolism |
650 | 0 | 4 |
_aEthylenes _xpharmacokinetics |
650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
650 | 0 | 4 |
_aHemoglobins _xmetabolism |
650 | 0 | 4 |
_aHypoxanthine Phosphoribosyltransferase _xgenetics |
650 | 0 | 4 | _aInhalation Exposure |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred F344 |
650 | 0 | 4 |
_aT-Lymphocytes _xenzymology |
650 | 0 | 4 |
_aValine _xanalogs & derivatives |
700 | 1 | _aWu, K Y | |
700 | 1 | _aUpton, P B | |
700 | 1 | _aRanasinghe, A | |
700 | 1 | _aScheller, N | |
700 | 1 | _aCho, M H | |
700 | 1 | _aVergnes, J S | |
700 | 1 | _aSkopek, T R | |
700 | 1 | _aSwenberg, J A | |
773 | 0 |
_tCarcinogenesis _gvol. 21 _gno. 9 _gp. 1661-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/carcin/21.9.1661 _zAvailable from publisher's website |
999 |
_c10911596 _d10911596 |